Company Search:
Advanced Search
Sponsored Links
Symbio Pharmaceuticals Ltd Company Snapshot
Symbio Pharmaceuticals Ltd operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Symbio Pharmaceuticals Ltd with three other companies in this sector in Japan: Trans Genic Inc (2016 sales of 2.29 billion Japanese Yen [US$20.36 million] of which 48% was CRO Business), Medical Data Vision Co Ltd (2.63 billion Japanese Yen [US$23.40 million] of which 55% was Data network service), and Medinet Co., Ltd. (1.91 billion Japanese Yen [US$16.97 million] of which 98% was cell processing).

Sales Analysis. Symbio Pharmaceuticals Ltd reported sales of ¥2.37 billion (US$21.05 million) for the year ending December of 2016. This represents an increase of 22.5% versus 2015, when the company's sales were ¥1.93 billion.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Symbio Pharmaceuticals Ltd
  Stock Performance Chart for Symbio Pharmaceuticals Ltd
  Stock Data: Recent Stock Performance:
  Current Price (12/15/2017): 220.00
(Figures in Japanese Yen)
1 Week 1.4%   13 Weeks -1.3%  
4 Weeks -6.0%   52 Weeks -16.0%  
Symbio Pharmaceuticals Ltd Key Data:
  Ticker: 4582 Country: Japan
  Exchanges: TYO JSQ Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 2,368,112,000
(Year Ending Jan 2017).
Employees: 77
  Currency: Japanese Yen Market Cap: 11,148,400,780
  Fiscal Yr Ends: December Shares Outstanding: 50,674,549
  Share Type: Common Closely Held Shares: 7,768,600
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.